NCT05485467View on ClinicalTrials.gov

The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

August 15, 2022

Study Completion Date

August 31, 2022

Conditions
VasculopathyHeart Transplant Failure
Interventions
DIAGNOSTIC_TEST

coronary CT angiography

Coronary CT angiography will be performed on multislice Siemens Somat Force CT scanner

Trial Locations (1)

1000

Advanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER